VITALE, MARIO
VITALE, MARIO
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
2001 Bifulco, M; Laezza, C; Portella, Giuseppe; Vitale, Mario; Orlando, P; De Petrocellis, L; Di, ; Marzo, V.
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
2001 Bifulco, M.; Laezza, C.; Portella, Giuseppe; Vitale, Mario; Orlando, P.; De Petrocellis, L.; Di Marzo, V.
Fibronectin is requiredto prevent thyroid cell apoptosis through an integrin-mediated adhesionmechanism.
1998 Vitale, Mario; Di Matola, T.; Fenzi, G.; Illario, Maddalena; Rossi, G.
revalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.
2010 Guerra, A.; Sapio, M. R.; Marotta, V.; Campanile, E.; Moretti, M. I.; Deandrea, M.; Motta, M.; Limone, P. P.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario
High-doseintravenous corticosteroid therapy for Graves' ophthalmopathy. J EndocrinolInvest. 2001 Mar;24(3):152-8
2001 Macchia, Pe; Bagattini, M; Lupoli, Giovanni; Vitale, Mario; Vitale, G; Fenzi, G.
Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cellsthrough a p53-independent CrmA-sensitive, and caspase-3-like protease-dependentmechanism.
1999 Vitale, Mario; Di Matola, T.; Rossi, G.; Laezza, C.; Fenzi, G.; Bifulco, M.
Cell-to-cellcontact modulates the expression of the beta 1 family of integrins in primarycultures of thyroid cells.
1995 Vitale, Mario; Casamassima, A.; Illario, Maddalena; Bassi, V.; Fenzi, G.; Rossi, G.
Inhibitors of Ras farnesylation revert the increased resistance tooxidative stress in K-Ras transformed NIH 3T3 cells.
1996 Santillo, Mariarosaria; Mondola, Paolo; Gioielli, A.; Serù, R.; Iossa, S.; Annella, T.; Vitale, Mario; Bifulco, M.
Growing thyroid nodules with benign histology and RET rearrangement.
2010 Marotta, V.; Guerra, Anna; Sapio, MARIA ROSARIA; Campanile, E.; Motta, M.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario
Desethylamiodarone antagonizes the effect ofthyroid hormone at the molecular level.
2001 Bogazzi, F; Bartalena, L; Brogioni, S; Burelli, A; Raggi, F; Ultimieri, F; Cosci, C; Vitale, Mario; Fenzi, G; Martino, E.
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C.
1997 Piazza, M.; Tosone, G.; Borgia, G.; Orlando, R.; Fenzi, G.; Vitale, Mario; Bloise, A.; Mariano, A.; Macchia, V.
Lovastatin-induced apoptosis in thyroid cells: involvement of cytochrome c andlamin B.
2001 Di Matola, T; D'Ascoli, F; Luongo, C; Bifulco, M; Rossi, G; Fenzi, G; Vitale, Mario
Analysis of cancer/testis antigensin sporadic medullary thyroid carcinoma: expression and humoral response toNY-ESO-1.
2003 Maio, M.; Coral, S.; Sigalotti, L.; Elisei, R.; Romei, C.; Rossi, G.; Cortini, E.; Colizzi, F.; Fenzi, G.; Altomonte, M.; Pinchera, A.; Vitale, Mario
Lamininreceptors in differentiated thyroid tumors: restricted expression of the67-kilodalton laminin receptor in follicular carcinoma cells.
1999 Montuori, Nunzia; Müller, F.; De Riu, S.; Fenzi, G.; Sobel, M. E.; Rossi, G.; Vitale, Mario
Integrinbinding to immobilized collagen and fibronectin stimulates the proliferation ofhuman thyroid cells in culture.
1997 Vitale, Mario; Illario, Maddalena; Di Matola, T.; Casamassima, A.; Fenzi, G.; Rossi, G.
Calcium/calmodulin–dependent kinase II (CaMKII) is constitutively activated in Thyroid carcinomas
2008 Vitale, Mario; Monaco, S.; Rusciano, M. R.; Salzano, M.; Moretti, M. I.; Fenzi, Gianfranco; Rossi, Guido; Illario, Maddalena
Dietary and hypothyroid hypercholesterolemiainduces hepatic apolipoprotein E expression in the rat: direct role ofcholesterol.
1999 Santillo, Mariarosaria; Migliaro, A.; Mondola, Paolo; Laezza, C.; Damiano, S.; Stingo, S.; Fiorentino, L.; Andreozzi, A.; Vitale, Mario; Bifulco, M.
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss offibronectin-integrin interaction.
2000 Di Matola, T.; Mueller, F.; Fenzi, G.; Rossi, G.; Bifulco, M.; Marzano, L. A.; Vitale, Mario
Thyroid cellular models: a warning concerning theirapplication.
2009 Vitale, Mario; Bifulco, M.
N6-isopentiladenosine induces apoptosis in thyroid cells
2008 Vitale, Mario; Di Matola, T.; Laezza, C.; Moretti, M. I.; Fenzi, Gianfranco; Rossi, Guido; Bifulco, M.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. | 1.1 Articolo in rivista | 2001 | Bifulco, M; Laezza, C; Portella, Giuseppe; Vitale, Mario; Orlando, P; De Petrocellis, L; Di, ; Marzo, V. | |
| Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. | 1.1 Articolo in rivista | 2001 | Bifulco, M.; Laezza, C.; Portella, Giuseppe; Vitale, Mario; Orlando, P.; De Petrocellis, L.; Di Marzo, V. | |
| Fibronectin is requiredto prevent thyroid cell apoptosis through an integrin-mediated adhesionmechanism. | 1.1 Articolo in rivista | 1998 | Vitale, Mario; Di Matola, T.; Fenzi, G.; Illario, Maddalena; Rossi, G. | |
| revalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application. | 1.1 Articolo in rivista | 2010 | Guerra, A.; Sapio, M. R.; Marotta, V.; Campanile, E.; Moretti, M. I.; Deandrea, M.; Motta, M.; Limone, P. P.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario | |
| High-doseintravenous corticosteroid therapy for Graves' ophthalmopathy. J EndocrinolInvest. 2001 Mar;24(3):152-8 | 1.1 Articolo in rivista | 2001 | Macchia, Pe; Bagattini, M; Lupoli, Giovanni; Vitale, Mario; Vitale, G; Fenzi, G. | |
| Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cellsthrough a p53-independent CrmA-sensitive, and caspase-3-like protease-dependentmechanism. | 1.1 Articolo in rivista | 1999 | Vitale, Mario; Di Matola, T.; Rossi, G.; Laezza, C.; Fenzi, G.; Bifulco, M. | |
| Cell-to-cellcontact modulates the expression of the beta 1 family of integrins in primarycultures of thyroid cells. | 1.1 Articolo in rivista | 1995 | Vitale, Mario; Casamassima, A.; Illario, Maddalena; Bassi, V.; Fenzi, G.; Rossi, G. | |
| Inhibitors of Ras farnesylation revert the increased resistance tooxidative stress in K-Ras transformed NIH 3T3 cells. | 1.1 Articolo in rivista | 1996 | Santillo, Mariarosaria; Mondola, Paolo; Gioielli, A.; Serù, R.; Iossa, S.; Annella, T.; Vitale, Mario; Bifulco, M. | |
| Growing thyroid nodules with benign histology and RET rearrangement. | 1.1 Articolo in rivista | 2010 | Marotta, V.; Guerra, Anna; Sapio, MARIA ROSARIA; Campanile, E.; Motta, M.; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario | |
| Desethylamiodarone antagonizes the effect ofthyroid hormone at the molecular level. | 1.1 Articolo in rivista | 2001 | Bogazzi, F; Bartalena, L; Brogioni, S; Burelli, A; Raggi, F; Ultimieri, F; Cosci, C; Vitale, Mario; Fenzi, G; Martino, E. | |
| Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. | 1.1 Articolo in rivista | 1997 | Piazza, M.; Tosone, G.; Borgia, G.; Orlando, R.; Fenzi, G.; Vitale, Mario; Bloise, A.; Mariano, A.; Macchia, V. | |
| Lovastatin-induced apoptosis in thyroid cells: involvement of cytochrome c andlamin B. | 1.1 Articolo in rivista | 2001 | Di Matola, T; D'Ascoli, F; Luongo, C; Bifulco, M; Rossi, G; Fenzi, G; Vitale, Mario | |
| Analysis of cancer/testis antigensin sporadic medullary thyroid carcinoma: expression and humoral response toNY-ESO-1. | 1.1 Articolo in rivista | 2003 | Maio, M.; Coral, S.; Sigalotti, L.; Elisei, R.; Romei, C.; Rossi, G.; Cortini, E.; Colizzi, F.; Fenzi, G.; Altomonte, M.; Pinchera, A.; Vitale, Mario | |
| Lamininreceptors in differentiated thyroid tumors: restricted expression of the67-kilodalton laminin receptor in follicular carcinoma cells. | 1.1 Articolo in rivista | 1999 | Montuori, Nunzia; Müller, F.; De Riu, S.; Fenzi, G.; Sobel, M. E.; Rossi, G.; Vitale, Mario | |
| Integrinbinding to immobilized collagen and fibronectin stimulates the proliferation ofhuman thyroid cells in culture. | 1.1 Articolo in rivista | 1997 | Vitale, Mario; Illario, Maddalena; Di Matola, T.; Casamassima, A.; Fenzi, G.; Rossi, G. | |
| Calcium/calmodulin–dependent kinase II (CaMKII) is constitutively activated in Thyroid carcinomas | 8.02 Comunicazioni a Convegni o Seminari | 2008 | Vitale, Mario; Monaco, S.; Rusciano, M. R.; Salzano, M.; Moretti, M. I.; Fenzi, Gianfranco; Rossi, Guido; Illario, Maddalena | |
| Dietary and hypothyroid hypercholesterolemiainduces hepatic apolipoprotein E expression in the rat: direct role ofcholesterol. | 1.1 Articolo in rivista | 1999 | Santillo, Mariarosaria; Migliaro, A.; Mondola, Paolo; Laezza, C.; Damiano, S.; Stingo, S.; Fiorentino, L.; Andreozzi, A.; Vitale, Mario; Bifulco, M. | |
| Serum withdrawal-induced apoptosis in thyroid cells is caused by loss offibronectin-integrin interaction. | 1.1 Articolo in rivista | 2000 | Di Matola, T.; Mueller, F.; Fenzi, G.; Rossi, G.; Bifulco, M.; Marzano, L. A.; Vitale, Mario | |
| Thyroid cellular models: a warning concerning theirapplication. | 1.1 Articolo in rivista | 2009 | Vitale, Mario; Bifulco, M. | |
| N6-isopentiladenosine induces apoptosis in thyroid cells | 8.02 Comunicazioni a Convegni o Seminari | 2008 | Vitale, Mario; Di Matola, T.; Laezza, C.; Moretti, M. I.; Fenzi, Gianfranco; Rossi, Guido; Bifulco, M. |